Home-Visiting Program Can Reduce Infant Health Care Use

Share this content:
Home-Visiting Program Can Reduce Infant Health Care Use
Home-Visiting Program Can Reduce Infant Health Care Use

THURSDAY, Dec. 15, 2016 (HealthDay News) -- A universal home visiting model that employs a nurse-parent educator team as visitors in the homes of primary caregivers and their first-born children can reduce health care use in the first year, according to a study published online Dec. 15 in Pediatrics.

M. Rebecca Kilburn, Ph.D., and Jill S. Cannon, Ph.D., from the RAND Corporation in Santa Monica, Calif., conducted a randomized clinical trial of an intensive visiting program delivered in homes of primary caregivers and their first-born children in Santa Fe, N.M. Two hundred forty-four primary caregivers participated in the survey.

The researchers found that the treatment-group children were one-third less likely to visit the emergency department in their first year of life (P = 0.02) and were 41 percent less likely to have visited a primary care provider nine or more times (P < 0.001). There was no between-group difference for hospitalizations or injuries requiring medical attention. For high-risk and lower-risk families, the universal program reduced infant health care use.

"Children in families randomly assigned to the program had less health care use in their first year, demonstrating that a universal prevention home visiting model delivered by a nurse-parent educator team can reduce infant health care use," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »